FDA
approval
· 2009-07-31
FDA Approved: MYOBLOC — Supplemental Application (Solstice Neurosciences, LLC)
Summary
The FDA approved a supplemental application for MYOBLOC (rimabotulinumtoxinB) from Solstice Neurosciences, LLC. This action confirms approval under the sponsor'…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MYOBLOC (RIMABOTULINUMTOXINB)